Equibles does not estimate personal net worth.
Get an email with a short summary when Denali Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get DNLI alertsJoe Lukak has spoken on 1 investor event across 1 company, most recently for Denali Therapeutics Inc. on November 11, 2026. Denali Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Denali Therapeutics Inc. includes Ryan J. Watts (CEO and Board Member), Alexander Schuth (CFO), Steve E. Krognes (CFO and Board Member) and 7 others.
“Very excited about the Avalaya launch so far. Seeing a lot of strong interest in the product and really what we're hearing from both patient families and KOLs is that the drug is really making an impact for patients, which is fantastic.”
Transcript header (unverified)
Biotechnology · Healthcare
